Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
McKinsey
Boehringer Ingelheim
Johnson and Johnson
Baxter
Mallinckrodt
Citi
Argus Health
Federal Trade Commission

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,105,659

« Back to Dashboard

Summary for Patent: 4,105,659
Title: 1,2,3,4,5,6-Hexahydro-2,6-methano-3-benzazocines
Abstract:1,2,3,4,5,6-Hexahydro-3-lower alkenyl-6-(R.sup.1)-11-(R.sup.2)-8-hydroxy-2,6-methano-3-benzazocines, wherein R.sup.1 and R.sup.2 are hydrogen or lower alkyl, and certain ethers and esters thereof, are obtained from analogous 3-unsubstituted compounds. The products have pharmacodynamic activity and are useful as antagonists of strong analgesic agents, such as morphine and meperidine, and are useful in humans as agents for producing analgesia.
Inventor(s): Archer; Sydney (Bethlehem, NY)
Assignee: Sterling Drug Inc. (New York, NY)
Application Number:04/342,768
Patent Claim Types:
see list of patent claims
Compound;

Drugs Protected by US Patent 4,105,659

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 4,105,659

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 246157 ➤ Try a Free Trial
Austria 252248 ➤ Try a Free Trial
Belgium 611000 ➤ Try a Free Trial
Brazil 6134479 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Boehringer Ingelheim
Federal Trade Commission
Accenture
US Army
Daiichi Sankyo
Fish and Richardson
Cipla
Covington
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.